40
Participants
Start Date
September 30, 2008
Primary Completion Date
March 31, 2010
Study Completion Date
April 30, 2010
Gemcitabine, Docetaxel, 5FU, Oxaliplatin
Gemcitabine: 1000 mg/m2 IV bolus days 1 and 8, repeated every 21 days x 8cycles Docetaxel: 40 mg/m2 IV bolus days 1 and 8, repeated every 21 days x 8 cycles Gemcitabine/docetaxel will be repeated (based upon initial response) Oxaliplatin: 40 mg/m2 IV on day 1 of each week of radiation 5-FU: 175 mg/m2 continuous infusion on days 1-18 and 29-46 of radiation
Alpha-interferon
Alpha-interferon: injected subcutaneously on days 1, 3, 5, 8, 10, 12, 15, 17, 29, 31, 33, 36, 38, 40, 43 and 46 during radiation therapy
Abdominal/pelvic radiation therapy
3-D conformal technique. The dose per fraction will be 180cGy, with a total dose of 5040 cGy in 28 fractions. Radiation therapy will be delivered on days 1-18 and days 29-46
Pancreaticoduodenectomy
Surgery performed if subject is considered candidate by protocol definition.
Virginia Mason Medical Center, Seattle
Lead Sponsor
Collaborators (1)
Sanofi
INDUSTRY
Benaroya Research Institute
OTHER